newsfilter
← Latest News
PR Newswire·

Fusion Pharmaceuticals to Present at Upcoming September Investor Conferences

HAMILTON, ON and BOSTON, Sept. 5, 2023 /CNW/ -- Fusion Pharmaceuticals Inc. (NASDAQ:FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today